What a great Quarterly
Love this...Merck
During May we agreed pricing with Merck for the OEM development of the 300nm AnteoBind
activated Europium particle. In a separate meeting we tabled contracts which Merck are now
assessing. Merck have also flagged potential to extend the product range in the future. Our
discussions with Merck remain on track to support a Q1 2021 launch of a combined product set
and
Ellume
We delivered an increased quantity of AnteoBind reagent to Ellume in this quarter and have
received forecast requirement from Ellume for 2020/2021, which requests for increasing
volumes of AnteoBind.
Awesome !!
Qtly, page-26
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.001(4.35%) |
Mkt cap ! $59.14M | |||
| Open | High | Low | Value | Volume |
| 2.3¢ | 2.4¢ | 2.3¢ | $27.19K | 1.178M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 3209855 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 1133619 | 8 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.4¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.3¢ | 2.4¢ | 2.3¢ | 807050 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| ADO (ASX) Chart |